ArticleInternational journal of immunopathology and pharmacology

Aurora-A promotes lenvatinib resistance experimentally through hsa-circ-0058046/miR-424-5p/FGFR1 axis in hepatocellular carcinoma.

Mubalake Abudoureyimu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.